Envirosuite share price flat after FY20 results

The Envirosuite share price is flatlining today after the the environmental management company posted its FY20 results.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Envirosuite Ltd (ASX: EVS) share price is trading flat today after the company posted its FY20 results. The share price is trading at 16 cents at the time of writing, after reaching as high as 17 cents in morning trade. Envirosuite is an environmental management technology company that helps customers with compliance around environmental management. Many client companies extend their business relationship, however, because the Software-as-a-Service platform enables them to unlock value beyond compliance monitoring.

Envirosuite FY 2020 results

The Envirosuite share price tumbled 27% from its early highs in FY20. Despite this, the company achieved a number of business objectives in FY20.

Envirosuite posted $24 million of revenue of which 75% is recurring. This is an increase of 210% in the company's revenue. However, the cost of revenue grew an even greater amount, increasing by 229%. This lead to an $18 million operating loss for the company.

It's not necessarily bad news as the operating loss was a result of the company establishing operations with China, a huge potential market for Envirosuite. The loss was also driven by increased investment in people and operation and integration costs of EMS business. As a result, the company announced negative adjusted EBITDA of $12 million.

However, the SaaS company said it would remove $8 million in costs due to duplicate and redundant roles. An additional $3 million will be cut as a result of operational synergies. The cuts are expected to be made in early FY21.

The company has $24.4 million in cash and cash equivalents. However, $4.2 million is earmarked for the remaining settlement for EMS and another $1.3 million for the AqMB acquisition.

Outlook for the Envirosuite share price

Looking ahead, Envirosuite shareholders have plenty to be excited about. The company has a 3-stage expansion plan with a target of $100 million in revenue by June 2023. Envirosuite is currently achieving annual recurring revenue of $43 million.

While the company has not disclosed a revenue target for FY21, it expects to be EBITDA-positive by March next year.

Motley Fool contributor Daniel Ewing owns shares of EnviroSuite Ltd. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

Businessman smiles with arms outstretched after receiving good news.
Share Gainers

Here are the top 10 ASX 200 shares today

It was another strong showing from the share market today.

Read more »

Three miners looking at a tablet.
Resources Shares

Own ASX mining shares? Experts say an upswing in commodity prices has begun

HSBC economists Paul Bloxham and Jamie Culling explain why global commodity prices are rising.

Read more »

A woman with a sad face looks to be receiving bad news on her phone as she holds it in her hands and looks down at it.
Share Fallers

Why Brambles, Lifestyle Communities, Northern Star, and Select Harvests shares are sinking

These shares are having a tough session. But why?

Read more »

A young woman sits at her desk in deep contemplation with her hand to her chin while seriously considering information she is reading on her laptop
Share Market News

Will the Reserve Bank wait for the US Fed to cut interest rates first?

Here's when AMP thinks interest rates will be cut in the US, Australia, New Zealand, Canada and the Eurozone.

Read more »

A young woman holding her phone smiles broadly and looks excited, after receiving good news.
Share Gainers

Healthco Healthcare, Medadvisor, Ramsay Health Care, and Tamboran shares are rising

These shares are having a strong session. But why?

Read more »

drug capsule opening up to reveal dollar signs signifying rising asx share price
Share Gainers

If you invested $6,000 in Mesoblast shares a month ago you'd have $15,636 now!

Mesoblast shares have been on a tear this past month. But why?

Read more »

Gold bars on top of gold coins.

Is it too late to buy gold as an investment in 2024?

Can we still take advantage of gold at new record highs?

Read more »

A female broker in a red jacket whispers in the ear of a man who has a surprised look on his face as she explains which two ASX 200 shares should do well in today's volatile climate
Mergers & Acquisitions

Wesfarmers shares baulk on fresh acquisition gossip

A healthcare company gone nowhere in a decade might be on Wesfarmers' radar.

Read more »